Inhibition of tyrosinase reduces cell viability in catecholaminergic neuronal cells

被引:35
作者
Higashi, Y [1 ]
Asanuma, M [1 ]
Miyazaki, I [1 ]
Ogawa, N [1 ]
机构
[1] Okayama Univ, Sch Med, Dept Neurosci, Inst Mol & Cellular Med, Okayama 7008558, Japan
关键词
tyrosinase; phenylthiourea; 5-hydroxyindole; dopamine; catecholaminergic neuron; melanin;
D O I
10.1046/j.1471-4159.2000.0751771.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biosynthesis of dopamine (DA) in catecholaminergic neurons is regulated by tyrosine hydroxylase, which converts tyrosine into 3,4-dihydroxyphenylalanine (L-DOPA). In melanocytes, tyrosinase catalyzes both the hydroxylation of tyrosine and the consequent oxidation of L-DOPA to form melanin. Although ii has been demonstrated that tyrosinase is also expressed in the brain. the physiological role of tyrosinase in the brain is stilt obscure. In this study. to investigate the role of tyrosinase in catecholaminergic neuronal cells, we examined the effects of tyrosinase inhibition on the viability of CATH,a and SH-SY5Y cells using tyrosinase inhibitors-specifically, phenylthiourea (PTU) and 5-hydroxyindole (5-HI)-and the transfection of antisense tyrosinase cDNA. Both inhibitors significantly reduced the cell viability of CATH.a cells in a dose-dependent manner. PTU also specifically enhanced DA-induced cell death, but 5-HI did not. This discrepancy in cell death is probably due to the inhibitors' different mechanism of action: 5-HI inhibits the hydroxylation or tyrosine as a competitor for the substrate to induce cell death that may be due to depletion of DA, whereas PTU mainly inhibits the enzymatic oxidation of L-DOPA and DA rather than tyrosine hydroxylation to increase consequently autooxidation of DA. Indeed. the intracellular DA content in CATH.a cells was enhanced by PTU exposure. In contrast, PTU showed no enhancing effects on DA-induced cell death of SH-SY5Y cells, which express little tyrosinase. Furthermore. transfection with antisense tyrosinase cDNA into CATH.a cells dramatically reduced cell viability and significantly enhanced DA-induced cell death. These results suggest that tyrosinase controls the intracellular DA content by biosynthesis or enzymatic oxidation of DA, and the dysfunction of this activity induces cell death by elevation of intracellular DA level and consequent gradual autooxidation of DA to generate reactive oxygen species.
引用
收藏
页码:1771 / 1774
页数:4
相关论文
共 23 条
[1]   EFFECTS OF SINGLE CYCLOSPORINE-A PRETREATMENT ON PENTYLENETETRAZOL-INDUCED CONVULSION AND ON TRE-BINDING ACTIVITY IN THE RAT-BRAIN [J].
ASANUMA, M ;
NISHIBAYASHI, S ;
KONDO, Y ;
IWATA, E ;
TSUDA, M ;
OGAWA, N .
MOLECULAR BRAIN RESEARCH, 1995, 33 (01) :29-36
[2]   Induction of apoptosis by the transcription factor c-Jun [J].
BossyWetzel, E ;
Bakiri, L ;
Yaniv, M .
EMBO JOURNAL, 1997, 16 (07) :1695-1709
[3]   An investigation of noradrenaline uptake and release by the CATH.a cell line [J].
Bundey, RA ;
Jones, PG ;
Kendall, DA .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (02) :799-806
[4]  
CHADER GJ, 1975, INVEST OPHTH VISUAL, V14, P108
[5]   Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis [J].
Iwata-Ichikawa, E ;
Kondo, Y ;
Miyazaki, I ;
Asanuma, M ;
Ogawa, N .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) :2334-2344
[6]   SEQUENCE-ANALYSIS OF MOUSE TYROSINASE CDNA AND THE EFFECT OF MELANOTROPIN ON ITS GENE-EXPRESSION [J].
KWON, BS ;
WAKULCHIK, M ;
HAQ, AK ;
HALABAN, R ;
KESTLER, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 153 (03) :1301-1309
[7]   Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells - Effects of oxidative stress and antioxidative factors [J].
Lai, CT ;
Yu, PH .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (03) :363-372
[8]  
LASKIN JD, 1986, J BIOL CHEM, V261, P16226
[9]   Characterization of density-dependent regulation of the tyrosinase gene promoter: Role of protein kinase C [J].
Mahalingam, H ;
Watanabe, A ;
Tachibana, M ;
Niles, RM .
EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) :83-92
[10]  
Masserano JM, 1996, MOL PHARMACOL, V50, P1309